• Pol. Arch. Med. Wewn. · Jan 2025

    Prevalence of cardiovascular comorbidities in psoriatic arthritis: relationship to clinical phenotype and treatment in a real-life study.

    • Jarosław Nowakowski, Piotr Kuszmiersz, Grzegorz Biedroń, Zofia Guła, Magdalena Strach, Glenn Haugeberg, and Mariusz Korkosz.
    • Pol. Arch. Med. Wewn. 2025 Jan 2.

    IntroductionThe relationship between the phenotype and treatment of psoriatic arthritis (PsA) and the increased prevalence of cardiovascular comorbidities is not well studied.ObjectiveTo assess the prevalence of cardiovascular comorbidities in relation to the clinical phenotype and treatment of PsA.MethodsThis was a cross-sectional, real-life study. Demographic and clinical data were recorded in patients with PsA. The relationships between clinical phenotypes (axial, oligoarthritis, polyarthritis, and mixed), cardiovascular risk factors, comorbidities, and treatment were analyzed.ResultsAmong the 267 patients studied, no differences were found between the prevalence of cardiovascular risk factors or comorbidities in relation to the clinical phenotypes of PsA. However, patients with oligoarthritis had hypertension more frequently (38.8% vs 22.0%, p=0.011). Patients with any cardiovascular disease were more often under current treatment with glucocorticosteroids (17.9% vs 4.8%, p=0.001) as well as exposed to them in the past (22.6% vs 13.%, p=0.02). 83.3% of patients with ongoing non-steroidal anti-inflammatory drugs (NSAIDs) had heart failure compared to patients without heart failure among whom 35.3% were currently taking NSAIDs (p=0.03). 15.4% of patients had diagnosed dyslipidemia but LDL level greater than 3.0 mmol/l was detected in 36.6% of patients. Multivariable logistic regression analysis identified the current use of glucocorticosteroids and oligoarthritis as predictive factors for cardiovascular comorbidities.ConclusionThe use of glucocorticoids and NSAIDs is associated with an increased prevalence of cardiovascular comorbidities in patients with PsA and should be avoided. Oligoarthritis and the current use of glucocorticosteroids are predictors of cardiovascular comorbidities. Hyperlipidemia remains underrecognized in patients with PsA within a real-world context.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!

We guarantee your privacy. Your email address will not be shared.